GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zim Laboratories Ltd (BOM:541400) » Definitions » Short-Term Capital Lease Obligation

Zim Laboratories (BOM:541400) Short-Term Capital Lease Obligation : ₹33 Mil (As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Zim Laboratories Short-Term Capital Lease Obligation?

Zim Laboratories's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹33 Mil.

Zim Laboratories's quarterly Short-Term Capital Lease Obligation declined from Mar. 2024 (₹25 Mil) to Jun. 2024 (₹0 Mil) but then increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹33 Mil).

Zim Laboratories's annual Short-Term Capital Lease Obligation increased from Mar. 2022 (₹14 Mil) to Mar. 2023 (₹16 Mil) and increased from Mar. 2023 (₹16 Mil) to Mar. 2024 (₹25 Mil).

Zim Laboratories Short-Term Capital Lease Obligation Historical Data

The historical data trend for Zim Laboratories's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zim Laboratories Short-Term Capital Lease Obligation Chart

Zim Laboratories Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.70 10.82 14.07 15.72 24.72

Zim Laboratories Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.37 - 24.72 - 33.38

Zim Laboratories Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Zim Laboratories Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Zim Laboratories's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Zim Laboratories Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zim Laboratories Ltd (BOM:541400) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
NSE:SAKAR BOM:540937 BOM:506414 BOM:532649 BOM:532305 BOM:524075 BOM:506260 BOM:540737 BOM:543329 BOM:524500 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
ZIMLAB:India
Address
Nelson Square, Chhindwara Road, Sadoday Gyan, Ground Floor, Opposite NADT, Nagpur, MH, IND, 440 013
Website
https://www.zimlab.in
Zim Laboratories Ltd is a pharmaceutical company. The company is mainly engaged in the manufacturing of formulation drugs and pre-formulation ingredients. Geographically, the group has a business presence in India and other countries, of which key revenue is derived from Outside India. The products offered by the company are Ondansetron, Melatonin, Nicotine, Vitamin D3, and others. The majority of its revenue is derived from the sale of pharmaceutical goods.

Zim Laboratories Headlines

No Headlines